<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="sub-sub-section" /><meta name="keywords" content="Hepatitis B: chronic; Interferon: alfa: chronic hepatitis B; Adefovir; Entecavir; Lamivudine: chronic hepatitis B; Tenofovir: chronic hepatitis B; Telbivudine" /><meta name="IX" content="Hepatitis B: chronic; Interferon: alfa: chronic hepatitis B; Adefovir; Entecavir; Lamivudine: chronic hepatitis B; Tenofovir: chronic hepatitis B; Telbivudine" /><title>5.3.3.1 Chronic hepatitis B: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="217714.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="217714.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=217714.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2071.htm">5 Infections</a> &gt; <a href="3992.htm">5.3 Antiviral drugs</a> &gt; <a href="128399.htm">5.3.3 Viral hepatitis</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="128399.htm" title="Previous: 5.3.3 Viral hepatitis">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="127968.htm" title="Next: ADEFOVIR DIPIVOXIL">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information (11)</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a396011.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Lamivudine</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Anti-infective Agents 8:00 &gt; Antivirals 8:18 &gt; Antiretrovirals 8:18.08 &gt; Nucleoside and Nucleotide Reverse Transcriptase Inhibitors 8:18.08.20</p></div></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a301063.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Tenofovir Disoproxil Fumarate</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Anti-infective Agents 8:00 &gt; Antivirals 8:18 &gt; Antiretrovirals 8:18.08 &gt; Nucleoside and Nucleotide Reverse Transcriptase Inhibitors 8:18.08.20</p></div></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a301061.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interferon Alfa (Antiviral)</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Anti-infective Agents 8:00 &gt; Antivirals 8:18 &gt; Interferons 8:18.20</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22hepatitis+b%22%22interferon%22%22adefovir%22%22entecavir%22%22lamivudine%22%22tenofovir%22%22telbivudine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (11)</a></li></ul><ul><li><h3>Stockley's Interaction Alerts (9)</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/17807-w.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Adefovir</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: A &gt; Interactions of Adefovir</p></div></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/20544-s.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Entecavir</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: E &gt; Interactions of Entecavir</p></div></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/12818-t.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Hepatitis b vaccines</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: H &gt; Interactions of Hepatitis b vaccines</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22hepatitis+b%22%22interferon%22%22adefovir%22%22entecavir%22%22lamivudine%22%22tenofovir%22%22telbivudine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (9)</a></li></ul><ul><li><h3>British National Formulary (46)</h3></li><li><a href="128394.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.3.1 HIV infection</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs</p></div></li><li><a href="129292.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Kivexa®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs &gt; 5.3.1 HIV infection &gt; Nucleoside reverse transcriptase inhibitors &gt; ABACAVIR &gt; With lamivudine</p></div></li><li><a href="106113.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Trizivir®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs &gt; 5.3.1 HIV infection &gt; Nucleoside reverse transcriptase inhibitors &gt; ABACAVIR &gt; With lamivudine and zidovudine</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22hepatitis+b%22%22interferon%22%22adefovir%22%22entecavir%22%22lamivudine%22%22tenofovir%22%22telbivudine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (46)</a></li></ul><ul><li><h3>BNF for Children (33)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/129083.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.3.1 HIV infection</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/129392.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Kivexa®</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs &gt; 5.3.1 HIV infection &gt; Nucleoside reverse transcriptase inhibitors &gt; ABACAVIR &gt; With lamivudine</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/106113.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Trizivir®</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs &gt; 5.3.1 HIV infection &gt; Nucleoside reverse transcriptase inhibitors &gt; ABACAVIR &gt; With lamivudine and zidovudine</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22hepatitis+b%22%22interferon%22%22adefovir%22%22entecavir%22%22lamivudine%22%22tenofovir%22%22telbivudine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (33)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK0923.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Lamivudine</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; L</p></div></li></ul><ul><li><h3>Handbook on Injectable Drugs</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a597012.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interferon Alfa-2b</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; I</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0004s0422-n.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Entecavir</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; E</p></div></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0009s0079.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interferon α 2b</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; I</p></div></li></ul><ul><li><h3>Kucers' the Use of Antibiotics (41)</h3></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/lamivudine_description.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Description</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Anti-Viral Drugs &gt; Inhibitors of Reserve Transcriptase &gt; 223 Lamivudine</p></div></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/lamivudine_antimicrobial_activity.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Antimicrobial activity</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Anti-Viral Drugs &gt; Inhibitors of Reserve Transcriptase &gt; 223 Lamivudine</p></div></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/lamivudine_mechanism_of_drug_action.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Mechanism of drug action</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Anti-Viral Drugs &gt; Inhibitors of Reserve Transcriptase &gt; 223 Lamivudine</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22hepatitis+b%22%22interferon%22%22adefovir%22%22entecavir%22%22lamivudine%22%22tenofovir%22%22telbivudine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (41)</a></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (17)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/ms-17807-w.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Adefovir</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antivirals &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/20544-s.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Entecavir</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antivirals &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/11419-t.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interferon Alfa</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antivirals &gt; Drug Monographs</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22hepatitis+b%22%22interferon%22%22adefovir%22%22entecavir%22%22lamivudine%22%22tenofovir%22%22telbivudine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (17)</a></li></ul><ul><li><h3>The Merck Index (9)</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/00151.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Adefovir</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; A &gt; AD</p></div></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/03595.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Entecavir</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; E &gt; EN</p></div></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/04989.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interferon</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; I &gt; IN</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22hepatitis+b%22%22interferon%22%22adefovir%22%22entecavir%22%22lamivudine%22%22tenofovir%22%22telbivudine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (9)</a></li></ul><ul><li><h3>Stockley's Drug Interactions (9)</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E46E3E0R0D3546.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Adefovir</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; A</p></div></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E6E3E0R0D3560.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Entecavir</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; E</p></div></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E14E3E0R0D2096.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Hepatitis b vaccines</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; H</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22hepatitis+b%22%22interferon%22%22adefovir%22%22entecavir%22%22lamivudine%22%22tenofovir%22%22telbivudine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (9)</a></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c209.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Lamivudine</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; L</p></div></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c358.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Tenofovir disoproxil</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; T</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_217714">5.3.3.1 Chronic hepatitis B</h1><?highlighter on?><div id="pC" class="jN"><div><p><b>Peginterferon alfa</b> (<a title="monograph-family: Interferon alfa" href="37082.htm#_37082">section 8.2.4</a>) is an option for the initial
treatment of chronic hepatitis B and may be preferable to <b>interferon alfa</b>. The use of peginterferon alfa and interferon
alfa is limited by a response rate of 30–40% and relapse is frequent.
Treatment should be discontinued if no improvement occurs after 4
months. The manufacturers of peginterferon alfa-2a and interferon
alfa contraindicate use in decompensated liver disease, but low doses
can be used with great caution in these patients. Although interferon
alfa is contra-indicated in patients receiving immunosuppressant treatment
(or who have received it recently), cautious use of peginterferon
alfa-2a may be justified in some cases.</p><p><b>Entecavir</b> or <a title="monograph: TENOFOVIR DISOPROXIL" href="106524.htm#_106524"><b>tenofovir disoproxil</b></a> are options for the initial
treatment of chronic hepatitis B. If the response is inadequate after
6–9 months of treatment, a change in treatment should be considered.
Other drugs that are licensed for the treatment of chronic hepatitis
B include <b>adefovir dipivoxil</b>, <a title="monograph: LAMIVUDINE" href="57101.htm#_57101"><b>lamivudine</b></a>, or <b>telbivudine</b> (but see NICE guidance below). </p><p>Entecavir alone, tenofovir disoproxil alone, or a combination
of lamivudine with either adefovir dipivoxil or tenofovir disoproxil
can be used in patients with decompensated liver disease.</p><p>If drug-resistant hepatitis B virus emerges during treatment,
another antiviral drug to which the virus is sensitive should be added.
Hepatitis B viruses with reduced susceptibility to lamivudine have
emerged following extended therapy. Adefovir or tenofovir can be given
with lamivudine in lamivudine-resistant chronic hepatitis B; telbivudine
or entecavir should not be used because cross-resistance can occur.</p><p>If there is no toxicity or loss in efficacy, treatment with
adefovir, entecavir, lamivudine, telbivudine, or tenofovir is usually
continued until 6 months after adequate seroconversion has occurred.
Treatment is usually continued long-term in patients with decompensated
liver disease.</p><p>Tenofovir, or a combination of tenofovir with either emtricitabine
or lamivudine may be used with other antiretrovirals, as part of ‘highly
active antiretroviral therapy’ (<a title="sub-section: HIV infection" href="128394.htm#_128394">section 5.3.1</a>) in patients who require treatment
for both HIV and chronic hepatitis B. If patients infected with both
HIV and chronic hepatitis B only require treatment for chronic hepatitis
B, they should receive antivirals that are not active against HIV,
such as peginterferon alfa or adefovir. Treatment may be continued
long-term, even if adequate seroconversion occurs. Management of these
patients should be coordinated between HIV and hepatology specialists.</p><div class="cN"><h2 class="cBR">NICE guidance</h2><h3 class="cBP">Entecavir and telbivudine for chronic hepatitis B
(August 2008)</h3><p>Entecavir is an option for the treatment of chronic hepatitis
B.</p><p>Telbivudine is not recommended for the treatment of chronic
hepatitis B. Patients currently receiving telbivudine can continue
treatment until they and their clinician consider it appropriate to
stop.</p></div><div class="cN"><h2 class="cBR">NICE guidance</h2><h3 class="cBP">Tenofovir disoproxil for the treatment of chronic
hepatitis B (July 2009)</h3><p>Tenofovir is an option for the treatment of chronic hepatitis
B.</p></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_127968"><a href="127968.htm" title="ADEFOVIR DIPIVOXIL">ADEFOVIR DIPIVOXIL</a></li><li id="_129890"><a href="129890.htm" title="ENTECAVIR">ENTECAVIR</a></li><li id="_200281"><a href="200281.htm" title="TELBIVUDINE">TELBIVUDINE</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="128399.htm">Previous: 5.3.3 Viral hepatitis</a> | <a class="top" href="217714.htm#">Top</a> | <a accesskey="]" href="127968.htm">Next: ADEFOVIR DIPIVOXIL</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>